BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30381579)

  • 1. The applied research of simultaneous image acquisition of T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) in the assessment of patients with prostate cancer.
    Liu Y; Wang W; Qin XB; Wang HH; Gao G; Zhang XD; Wang XY
    Asian J Androl; 2019; 21(2):177-182. PubMed ID: 30381579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
    Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
    J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition.
    Corcuera-Solano I; Wagner M; Hectors S; Lewis S; Titelbaum N; Stemmer A; Rastinehad A; Tewari A; Taouli B
    J Magn Reson Imaging; 2017 Dec; 46(6):1767-1775. PubMed ID: 28301097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
    Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
    J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance.
    Baur AD; Daqqaq T; Wagner M; Maxeiner A; Huppertz A; Renz D; Hamm B; Fischer T; Durmus T
    Eur J Radiol; 2016 Jun; 85(6):1075-84. PubMed ID: 27161055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
    Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
    Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
    Kim CK; Choi D; Park BK; Kwon GY; Lim HK
    J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality.
    Lee KL; Kessler DA; Dezonie S; Chishaya W; Shepherd C; Carmo B; Graves MJ; Barrett T
    Eur J Radiol; 2023 Sep; 166():111017. PubMed ID: 37541181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
    Zhang KS; Mayer P; Glemser PA; Tavakoli AA; Keymling M; Rotkopf LT; Meinzer C; Görtz M; Kauczor HU; Hielscher T; Stenzinger A; Bonekamp D; Hohenfellner M; Schlemmer HP
    Eur J Radiol; 2023 Oct; 167():111026. PubMed ID: 37639843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
    Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
    Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer: comparison with conventional two- and three-dimensional T2-weighted turbo spin-echo imaging.
    Tanaka U; Ueno Y; Morinaga Y; Miyake H; Kyotani K; Ueda Y; Kitajima K; Sofue K; Suenaga Y; Sugimura K; Takahashi S
    Jpn J Radiol; 2017 Dec; 35(12):707-717. PubMed ID: 28983811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality.
    Ullrich T; Quentin M; Oelers C; Dietzel F; Sawicki LM; Arsov C; Rabenalt R; Albers P; Antoch G; Blondin D; Wittsack HJ; Schimmöller L
    Eur J Radiol; 2017 May; 90():192-197. PubMed ID: 28583633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
    Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
    Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.